This vaccine has been reported to cause the induction of CD8+ T cell infiltration in a CXCL10 manner and up-regulation of immune inhibitory checkpoints such as CTLA-4 [86], thus showing that anti-cancer vaccines are interesting leads and require further investigation [82]. The gene discussed is CTLA4; the disease is cancer.